Restylane® Portfolio of Hyaluronic Acid Fillers
With more than 40 million treatments completed worldwide and counting, the Restylane line of hyaluronic acid (HA) dermal fillers is the broadest portfolio of fillers in the U.S. Restylane is the only line of fillers with treatments FDA-approved for both the face and hands. The fillers work by smoothing away facial wrinkles and folds (Restylane, Restylane Lyft, Restylane Refyne, Restylane Defyne), enhancing lips (Restylane, Restylane Silk), smoothing lines around the mouth (Restylane Silk), adding lift and volume to the cheeks (Restylane Lyft), and reversing the signs of volume loss in the back of aging hands (Restylane Lyft).
Restylane uses two types of technologies to deliver a natural and youthful-looking appearance. Certain Restylane products are formulated with XpresHAn Technology™, which are the only HA filler options proven to maintain natural facial expressions. Select Restylane products are formulated with NASHA Technology, which creates a firmer gel texture that allows for precise injection, leading to a more pronounced lift and smoother skin. All Restylane products deliver results that are natural-looking.
Restylane is formulated with lidocaine, which reduces pain during injection and post-injection to improve the treatment experience.
Restylane Refyne and Defyne
Restylane Refyne and Restylane Defyne, introduced in 2017, are FDA-approved to smooth smile and laugh lines. They are the only fillers designed with Galderma’s unique manufacturing process, XpresHAn Technology™, which creates a smooth, injectable gel that can give the skin a natural, soft look, and is proven to maintain natural movement in the lower part of the face. Since the lower part of the face is constantly in motion, it’s important to use a filler that supports natural movement and facial expressions.
Both Restylane Refyne and Restylane Defyne have been used outside the U.S. under the name Emervel since 2011, so safety and efficacy are well-established with more than one million treatments worldwide. Results with Restylane Refyne and Restylane Defyne are clinically proven to last up to 12 months.
Restylane Lyft is the first and only hyaluronic acid filler to be FDA-approved for both the face and hands – the midface/cheek area, nasolabial folds, marionette lines, oral commissures (lines at the corner of the mouth), and the back of the hands. Restylane Lyft restores volume to the cheeks and hands for a smoother, more youthful looking appearance. One of the most versatile products in the Restylane portfolio, Restylane Lyft, formerly known as Perlane, has been on the market for more than 10 years and has a proven track record of safety and efficacy. Results are clinically proven to last up to 18 months in the nasolabial folds, 12 months in the cheeks, and up to 6 months in facial wrinkles and folds in the hands.
Restylane Lyft was voted one of 2019’s “Most Worth It” nonsurgical procedures by RealSelf, with 99 percent of patients rating the treatment as “Worth It.”
Restylane Silk was the first FDA-approved filler specifically designed for lip augmentation and the smoothing of wrinkles around the mouth. Restylane Silk is designed specifically to provide natural-looking results in these areas, due to its unique formulation. The lip area is the second most common treatment area on the face, and Restylane Silk provides a solution for patients interested in subtly enhancing this area. Restylane Silk was approved in 2015 and has a proven safety record with results that last up to six months. In 2017, Restylane Silk also became the first and only lip filler FDA-approved to be injected via cannula, a thin, flexible tube with a small opening that may help minimize patient bruising and downtime.
With more than 20 years of clinical legacy, Restylane was the world’s first hyaluronic acid filler. Restylane is FDA-approved to help correct moderate to severe facial wrinkles and folds, including the lines from the nose to the corners of the mouth (nasolabial folds) and the lines from the corners of the mouth to the chin (marionette lines), and for enhancement of the lips.
Thanks but no thanks, frown lines.
Meet Jeuveau® (prabotulinumtoxinA-xvfs) injection–a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a period of time.
Jeuveau® prevents your nerves from telling your facial muscles to flex. The result? In clinical trials, Jeuveau® was shown to temporarily improve the appearance of moderate to severe frown lines. In 2 long-term safety studies, patients received an average of 3 treatments over the course of 1 year.
XEOMIN® (incobotulinumtoxinA) important consumer safety information
Read the Medication Guide before you start receiving XEOMIN® (Zeo-min) and each time XEOMIN® is given to you as there may be new information. The risk information provided here is not comprehensive. To learn more:
Uses XEOMIN® is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary).
It is not known if XEOMIN is safe and effective in children under 18 years of age.
Dysport® (abobotulinumtoxinA) is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age
Important Safety Information:
What is the most important information you should know about Dysport? Spread of Toxin Effects: In some cases, the effects of Dysport and all botulinum toxin products may affect areas of the body away from the injection site. Symptoms can happen hours to weeks after injection and may include swallowing and breathing problems, loss of strength and muscle weakness all over the body, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, or loss of bladder control. Swallowing and breathing problems can be life threatening and there have been reports of death. You are at the highest risk if these problems are pre‐existing before injection.
These effects could make it unsafe for you to drive a car, operate machinery, or do other dangerous activities.